Agnes, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 6.126
EU - Europa 5.791
AS - Asia 4.741
SA - Sud America 994
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 13
Totale 17.795
Nazione #
US - Stati Uniti d'America 5.973
SG - Singapore 2.188
DE - Germania 1.972
CN - Cina 1.485
SE - Svezia 940
BR - Brasile 836
UA - Ucraina 614
IT - Italia 584
FR - Francia 374
IE - Irlanda 291
GB - Regno Unito 272
FI - Finlandia 223
VN - Vietnam 220
PL - Polonia 199
ID - Indonesia 171
IN - India 142
TR - Turchia 98
RU - Federazione Russa 91
CA - Canada 78
HK - Hong Kong 71
AR - Argentina 66
BD - Bangladesh 57
BE - Belgio 55
JP - Giappone 55
MX - Messico 46
KR - Corea 45
IQ - Iraq 43
ZA - Sudafrica 42
IR - Iran 33
NL - Olanda 26
AT - Austria 24
EC - Ecuador 22
LT - Lituania 21
VE - Venezuela 21
ES - Italia 20
PK - Pakistan 19
SA - Arabia Saudita 19
CO - Colombia 18
CH - Svizzera 15
KE - Kenya 14
UZ - Uzbekistan 14
CI - Costa d'Avorio 13
EU - Europa 13
MA - Marocco 13
CZ - Repubblica Ceca 12
EG - Egitto 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
AU - Australia 9
DZ - Algeria 9
RO - Romania 9
PY - Paraguay 8
AZ - Azerbaigian 7
PA - Panama 7
PT - Portogallo 7
NP - Nepal 6
PH - Filippine 6
TH - Thailandia 6
UY - Uruguay 6
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
GR - Grecia 5
IL - Israele 5
LV - Lettonia 5
DK - Danimarca 4
EE - Estonia 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PE - Perù 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CR - Costa Rica 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
BZ - Belize 2
GA - Gabon 2
GD - Grenada 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
GE - Georgia 1
Totale 17.782
Città #
Chandler 988
Singapore 915
Ashburn 604
Jacksonville 348
Dublin 285
Beijing 284
San Mateo 273
Ann Arbor 203
Nanjing 189
New York 163
Jakarta 160
Warsaw 135
Hefei 130
Los Angeles 128
Boston 125
Munich 122
Rome 120
Wilmington 119
Woodbridge 115
Nürnberg 112
The Dalles 109
Marseille 103
Dearborn 92
Seattle 92
Lawrence 91
Milan 91
Bremen 83
Redwood City 81
Cattolica 80
Houston 79
Chicago 77
Frankfurt am Main 77
Dallas 76
Helsinki 75
Izmir 69
Nanchang 69
Ho Chi Minh City 65
Moscow 64
São Paulo 63
Hong Kong 62
Shenyang 60
Fairfield 57
Hanoi 56
Hangzhou 55
Princeton 53
Brussels 51
Buffalo 47
Lancaster 47
Zhengzhou 46
Hebei 42
Santa Clara 40
University Park 39
Tokyo 38
Augusta 37
Tianjin 35
Detroit 34
Mountain View 33
Andover 32
London 31
Shanghai 30
Changsha 29
Johannesburg 29
Kent 29
Nuremberg 29
Kraków 28
Rio de Janeiro 28
Seoul 27
Turku 27
Atlanta 26
Kunming 26
Norwalk 26
Toronto 26
Belo Horizonte 25
Guangzhou 25
Phoenix 23
Boardman 21
Pune 21
Baghdad 20
Jiaxing 20
Chengdu 19
Dhaka 19
Düsseldorf 19
Jinan 19
Brooklyn 18
Curitiba 18
Kish 18
Cambridge 16
Leawood 16
Ningbo 16
Montreal 15
Stockholm 15
Fremont 14
Guarulhos 14
Hounslow 14
Lauterbourg 14
Mexico City 14
Paris 14
Porto Alegre 14
Vienna 14
Da Nang 13
Totale 8.797
Nome #
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 332
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 289
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 236
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 221
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 204
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 198
Duplex Doppler in the postoperative monitoring of liver transplant recipients 191
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 190
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 172
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 170
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 169
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 166
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 166
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 156
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 153
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 153
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 149
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 149
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 148
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 145
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 144
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 142
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 140
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 139
Psychological risk factors for graft rejection among liver transplant recipients 137
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 137
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 137
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 135
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 135
Fungal infections after liver transplantation: incidence and outcome 135
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 135
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 133
Prediction of 6-month survival after liver transplantation using Cox regression. 132
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 132
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 132
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 132
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 131
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 129
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 129
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 129
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 128
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 127
Model for end-stage liver disease dynamic stratification of survival benefit 127
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 124
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 123
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 123
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 122
Is primary nonfunction still a suitable indication for liver retransplantation? 121
Psychological risk factors for graft rejection among liver transplant recipients 121
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 120
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 120
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 118
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 118
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 118
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 117
Overextended Criteria Donors: Experience of an Italian Transplantation Center 116
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 115
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 113
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 113
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 113
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 112
Lamivudine-induced muscle mitochondrial toxicity 112
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 112
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 111
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 110
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 110
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 110
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 108
Prediction of 6-month survival after liver transplantation using Cox regression 108
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 108
Pancreatic function assessment 107
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 106
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 106
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 106
Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles 105
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 105
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 105
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 104
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 104
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 104
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 103
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 103
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 102
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 102
Migration rate using Fully-covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT Study Group 102
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 100
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 100
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 99
Should retransplantation still be considered for primary non-function after liver transplantation? 97
Celiac axis compression syndrome in liver transplantation 97
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 96
Primary difunction after liver trasplantation: donor or recipients fault? 96
Effect of liver transplantation on intestinal permeability and correlation with infection episodes 96
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 95
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 95
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 95
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 95
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 94
Totale 13.052
Categoria #
all - tutte 75.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.369


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021700 0 0 0 0 0 53 139 19 147 77 241 24
2021/20221.456 88 187 28 105 71 47 10 259 62 83 199 317
2022/20232.818 323 364 260 434 183 364 149 210 311 70 120 30
2023/20241.356 55 428 39 148 58 176 89 43 16 49 128 127
2024/20252.991 45 79 237 114 277 80 80 146 472 307 653 501
2025/20263.877 1.192 184 436 748 1.217 100 0 0 0 0 0 0
Totale 17.946